CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing incidence of hospital-acquired infections
4.1.2. High incidence of sepsis in the adult population
4.1.3. Growing number of surgical procedures & burden of pneumonia.
4.1.4. Rising initiatives to increase the awareness and drive the adoption of sepsis diagnostic
tests.
4.1.5. Funding for sepsis-related research activities
4.2. Market Restraints & Challenges
4.2.1. Lack of established reimbursement policies for sepsis
4.2.2. The high cost of automated diagnostic devices
4.2.3. Shortage of skilled healthcare professionals
4.2.4. Lack of standard protocols and awareness for sepsis diagnosis and treatment
4.3. Market Opportunities
4.3.1. Evolution of novel biomarkers for sepsis diagnosis
4.3.2. Development of rapid diagnostic/POC techniques for early sepsis diagnosis
CHAPTER 5. GLOBAL SEPSIS DIAGNOSTICS MARKET – BY TECHNOLOGY
5.1. Immunoassay
5.2. Flow Cytometry
5.3. Microfluidics
5.4. Biomarkers
5.5. Molecular Diagnostics
5.5.1. Polymerase Chain Reaction
5.5.2. Peptide Nucleic Acid-Fluorescent in Situ Hybridization
5.5.3. Microarrays
5.5.4. Syndromic Panel-Based Testing
5.6. Microbiology
CHAPTER 6. GLOBAL SEPSIS DIAGNOSTICS MARKET – BY PRODUCT
6.1. Assays & Reagents
6.2. Software
6.3. Instruments
6.4. Blood Culture Media
CHAPTER 7. GLOBAL SEPSIS DIAGNOSTICS MARKET – BY METHOD
7.1. Automated Diagnostics
7.2. Conventional Diagnostics
CHAPTER 8. GLOBAL SEPSIS DIAGNOSTICS MARKET - BY PATHOGENT
8.1. Fungal Sepsis
8.2. Bacterial Sepsis
8.2.1. Gram-Negative Bacterial Sepsis
8.2.2. Gram-Positive Bacterial Sepsis
8.3. Others
CHAPTER 9. GLOBAL SEPSIS DIAGNOSTICS MARKET - BY TEST TYPE
9.1. Point-Of-Care Tests
9.2. Laboratory Tests
CHAPTER 10. GLOBAL SEPSIS DIAGNOSTICS MARKET - BY END USER
10.1. Pathology & Reference Laboratories
10.2. Hospitals
10.3. Others
CHAPTER 11. GLOBAL SEPSIS DIAGNOSTICS MARKET - BY GEOGRAPHY
11.1. Introduction
11.2. North America
11.2.1. U.S.
11.2.2. Canada
11.2.3. Mexico
11.2.4. Costa Rica
11.3. South America
11.3.1. Brazil
11.3.2. Argentina
11.3.3. Chile
11.3.4. Columbia
11.3.5. Others
11.4. Europe
11.4.1. U.K.
11.4.2. Germany
11.4.3. France
11.4.4. Italy
11.4.5. Spain
11.4.6. Russia
11.4.7. Netherlands
11.4.8. Switzerland
11.4.9. Poland
11.4.10. Others
11.5. APAC
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. South Korea
11.5.5. Australia & New Zealand
11.5.6. Malaysia
11.5.7. Singapore
11.5.8. Others
11.6. Middle East & Africa
11.6.1. UAE
11.6.2. Saudi Arabia
11.6.3. Iran
11.6.4. Iraq
11.6.5. Qatar
11.6.6. South Africa
11.6.7. Algeria
11.6.8. Morocco
11.6.9. Nigeria
11.6.10. Egypt
11.6.11. Others
CHAPTER 12. GLOBAL SEPSIS DIAGNOSTICS MARKET - COMPANY PROFILES
12.1. Danaher Corporation
12.2. Diasorin Molecular, LLC
12.3. Grifols, S.A
12.4. Biomérieux SA
12.5. Abbott Laboratories, Ltd.
12.6. Siemens AG
12.7. Becton, Dickinson and Company
12.8. Hologic, Inc.
12.9. Roche Diagnostics, Pvt. Ltd.
12.10. Qiagen N.V
12.11. Illumina, Inc.
12.12. Agilent Technologies, Inc
CHAPTER 13. GLOBAL SEPSIS DIAGNOSTICS MARKET - COMPETITIVE
LANDSCAPE
13.1. Market Share Analysis
13.2. Strategies adopted by top companies
13.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 14. MARKET INSIGHTS
14.1. Industry Experts Insights
14.2. Analysts Opinions
14.3. Investment Opportunities
CHAPTER 15. APPENDIX
15.1. List of Tables
15.2. List of Figures
